# UMH Properties, Inc.: financial statements, quarterly

UMH · NYSE · CIK 752642 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/umh.md) · [Financials](/companies/umh/financials.md) · [Filings](/companies/umh/filings.md) · [Insiders](/companies/umh/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/umh/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [56.0](/filings/0001493152-24-043831.md) | [57.0 d](/filings/0001493152-26-008042.md) | [57.7](/filings/0001641172-25-008105.md) | [60.3](/filings/0001493152-25-011648.md) | [60.7](/filings/0001493152-25-020593.md) | [61.9 d](/filings/0001493152-26-008042.md) | [61.2](/filings/0001493152-26-020513.md) | [66.6](/filings/0001493152-26-036177.md) | [66.9](/filings/0001493152-25-020593.md) | [67.0 d](/filings/0001493152-26-008042.md) | [65.8](/filings/0001493152-26-020513.md) | [71.6](/filings/0001493152-26-036177.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(1.5)](/filings/0001493152-24-043831.md) | [11.3 d](/filings/0001493152-26-008042.md) | [(1.6)](/filings/0001493152-25-020593.md) | [5.2](/filings/0001493152-25-020593.md) | [12.9](/filings/0001493152-25-020593.md) | [5.0 d](/filings/0001493152-26-008042.md) | [4.8](/filings/0001493152-26-036177.md) | [7.6](/filings/0001493152-26-036177.md) | [9.3](/filings/0001493152-25-020593.md) | [4.6 d](/filings/0001493152-26-008042.md) | [7.7](/filings/0001493152-26-036177.md) | [9.5](/filings/0001493152-26-036177.md) |
| Diluted EPS | $ per share | [(0.09)](/filings/0001493152-24-043831.md) | not reported | [(0.09)](/filings/0001641172-25-008105.md) | [0.01](/filings/0001493152-25-011648.md) | [0.11](/filings/0001493152-25-020593.md) | not reported | [0.00](/filings/0001493152-26-020513.md) | [0.03](/filings/0001493152-26-036177.md) | [0.05](/filings/0001493152-25-020593.md) | not reported | [0.03](/filings/0001493152-26-020513.md) | [0.05](/filings/0001493152-26-036177.md) |
| Basic EPS | $ per share | [(0.09)](/filings/0001493152-24-043831.md) | not reported | [(0.09)](/filings/0001641172-25-008105.md) | [0.01](/filings/0001493152-25-011648.md) | [0.11](/filings/0001493152-25-020593.md) | not reported | [0.00](/filings/0001493152-26-020513.md) | [0.03](/filings/0001493152-26-036177.md) | [0.05](/filings/0001493152-25-020593.md) | not reported | [0.03](/filings/0001493152-26-020513.md) | [0.05](/filings/0001493152-26-036177.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Interest expense: not reported
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [38.6](/filings/0001493152-24-043831.md) | [57.3](/filings/0001493152-26-008042.md) | [39.9](/filings/0001641172-25-008105.md) | [39.5](/filings/0001493152-25-011648.md) | [66.7](/filings/0001493152-25-020593.md) | [99.7](/filings/0001493152-26-036177.md) | [35.2](/filings/0001493152-26-020513.md) | [79.2](/filings/0001493152-26-036177.md) | [34.1](/filings/0001493152-25-020593.md) | [72.1](/filings/0001493152-26-036177.md) | [37.4](/filings/0001493152-26-020513.md) | [28.6](/filings/0001493152-26-036177.md) |
| Total assets | $m | [1,393](/filings/0001493152-23-039908.md) | [1,428](/filings/0001493152-25-008351.md) | [1,416](/filings/0001493152-24-017580.md) | [1,441](/filings/0001493152-24-030423.md) | [1,502](/filings/0001493152-24-043831.md) | [1,564](/filings/0001493152-26-008042.md) | [1,549](/filings/0001641172-25-008105.md) | [1,624](/filings/0001493152-25-011648.md) | [1,630](/filings/0001493152-25-020593.md) | [1,699](/filings/0001493152-26-036177.md) | [1,688](/filings/0001493152-26-020513.md) | [1,713](/filings/0001493152-26-036177.md) |
| Total liabilities | $m | [715](/filings/0001493152-23-039908.md) | [721](/filings/0001493152-25-008351.md) | [699](/filings/0001493152-24-017580.md) | [697](/filings/0001493152-24-030423.md) | [643](/filings/0001493152-24-043831.md) | [648](/filings/0001493152-26-008042.md) | [635](/filings/0001641172-25-008105.md) | [690](/filings/0001493152-25-011648.md) | [703](/filings/0001493152-25-020593.md) | [792](/filings/0001493152-26-036177.md) | [792](/filings/0001493152-26-020513.md) | [821](/filings/0001493152-26-036177.md) |
| Long-term debt | $m | [146](/filings/0001493152-23-039908.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [676](/filings/0001493152-23-039908.md) | [705](/filings/0001493152-25-008351.md) | [715](/filings/0001493152-24-017580.md) | [742](/filings/0001493152-24-030423.md) | [856](/filings/0001493152-24-043831.md) | [914](/filings/0001493152-26-008042.md) | [912](/filings/0001641172-25-008105.md) | [932](/filings/0001493152-25-011648.md) | [925](/filings/0001493152-25-020593.md) | [906](/filings/0001493152-26-036177.md) | [894](/filings/0001493152-26-020513.md) | [890](/filings/0001493152-26-036177.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [38.1 d](/filings/0001493152-24-043831.md) | [29.0 d](/filings/0001493152-26-008042.md) | [19.0](/filings/0001641172-25-008105.md) | [18.6 d](/filings/0001493152-25-011648.md) | [16.7 d](/filings/0001493152-25-020593.md) | [27.3 d](/filings/0001493152-26-008042.md) | [12.8](/filings/0001493152-26-020513.md) | [24.4 d](/filings/0001493152-26-036177.md) | [23.4 d](/filings/0001493152-25-020593.md) | [21.3 d](/filings/0001493152-26-008042.md) | [20.8](/filings/0001493152-26-020513.md) | [24.8 d](/filings/0001493152-26-036177.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [12.8 d](/filings/0001493152-24-043831.md) | [13.0 d](/filings/0001493152-26-008042.md) | [13.5](/filings/0001641172-25-008105.md) | [14.3 d](/filings/0001493152-25-011648.md) | [15.1 d](/filings/0001493152-25-020593.md) | [16.1 d](/filings/0001493152-26-008042.md) | [16.9](/filings/0001493152-26-020513.md) | [18.1 d](/filings/0001493152-26-036177.md) | [18.2 d](/filings/0001493152-25-020593.md) | [18.0 d](/filings/0001493152-26-008042.md) | [18.1](/filings/0001493152-26-020513.md) | [18.3 d](/filings/0001493152-26-036177.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [54.9](/filings/0001493152-23-039908.md) | [59.1](/filings/0001493152-24-017580.md) | [61.8](/filings/0001493152-24-030423.md) | [65.6](/filings/0001493152-24-043831.md) | [69.5](/filings/0001641172-25-008105.md) | [71.9](/filings/0001493152-25-011648.md) | [76.6](/filings/0001493152-25-020593.md) | [83.3](/filings/0001493152-26-020513.md) | [84.8](/filings/0001493152-26-036177.md) | [85.5](/filings/0001493152-25-020593.md) | [85.4](/filings/0001493152-26-020513.md) | [85.6](/filings/0001493152-26-036177.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 85,385,600 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001493152-26-036177.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.